Development of a colorimetric assay for rapid quantitative measurement of clavulanic acid in microbial samples

Science China Life Sciences

Volumn 55, Issue 2, 2012, Pages 158-163

  Dai, Xi Da ^a   Xiang, Si Hai ^b   Li, Jia ^b   Gao, Qiang ^a   Yang, Ke Qian ^b  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

lactamase; clavulanic acid; colorimetric assay; nitrocefin; Streptomyces clavuligerus

Indexed keywords

BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; NITROCEFIN;

ARTICLE; CHEMISTRY; COLORIMETRY; CULTURE MEDIUM; DRUG ANTAGONISM; GENETICS; GROWTH, DEVELOPMENT AND AGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; MUTATION; REPRODUCIBILITY; STREPTOMYCES;

BETA-LACTAMASES; CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLAVULANIC ACID; COLORIMETRY; CULTURE MEDIA, CONDITIONED; MUTATION; REPRODUCIBILITY OF RESULTS; STREPTOMYCES;

STREPTOMYCES CLAVULIGERUS;

EID: 84863286327     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-012-4287-x     Document Type: Article

References (14)

1. Ninane G, Joly J, Kraytman M, et al. Bronchopulmonary infection due to β-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid. Lancet, 1978, 2: 257.
2. Xiang S H, Li J, Yin H, et al. Application of a double-reporter-guided mutant selection method to improve clavulanic acid production in Streptomyces clavuligerus. Metab Eng, 2009, 11: 310-318.
3. Foulstone M, Reading C. Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography. Antimicrob Agents Chemother, 1982, 22: 753-762.
4. Gutman A L, Ribon V, Leblanc J P. Rapid and convenient spectrophotometric method for determination of clavulanic acid. Anal Chem, 1985, 57: 2344-2346.
5. Doran J L, Leskiw B K, Aippersbach S, et al. Isolation and characterization of a beta-lactamase-inhibitory protein from Streptomyces clavuligerus and cloning and analysis of the corresponding gene. J Bacteriol, 1990, 172: 4909-4918.
6. Legg B, Clarke J G, Davies B E, et al. Automated enzyme-inhibition assay for clavulanic acid in biological samples. J Pharm Biomed Anal, 1985, 3: 381-384.
7. Mendiratta D K, Kaur H, Deotale V, et al. Status of high level aminoglycoside resistant Enterococcus faecium and Enterococcus faecalis in a rural hospital of central India. Indian J Med Microbiol, 2008, 26: 369-371.
8. Tam V H, Schilling A N, Larocco M T, et al. Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa. Clin Microbiol Infect, 2007, 13: 413-418.
9. Hedberg M, Lindqvist L, Tuner K, et al. Effect of clavulanic acid, sulbactam and tazobactam on three different β-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum. J Antimicrob Chemother, 1992, 30: 17-25.
10. O'callaghan C H, Morris A, Kirby S M, et al. Novel method for detection of β-lactamases by using a chromogenic cephalosporin sub strate. Antimicrob Agents Chemother, 1972, 1: 283-288.
11. Santamarta I, Rodriguez-Garcia A, Perez-Redondo R, et al. CcaR is an autoregulatory protein that binds to the ccaR and cefD-cmcI promoters of the cephamycin C-clavulanic acid cluster in Streptomyces clavuligerus. J Bacteriol, 2002, 184: 3106-3113.
12. Fleming I D, Noble D, Noble H M, et al. Pure potassium salt of clavulanic acid. US Patent, 4367175, 1983-01-04.
13. Brethauer S, Held M, Panke S. High concentrations of clavulanic acid but not of its degradation products decrease glycerol consumption and oxygen uptake rates in cultures of Streptomyces clavuligerus. Biotechnol Bioeng, 2008, 100: 439-447.
14. Stirling I, Elson S W. Studies on the biosynthesis of clavulanic acid. II. Chemical degradations of 14C-labelled clavulanic acid. J Antibiot (Tokyo), 1979, 32: 1125-1129.